Oppenheimer reaffirms Outperform on Boston Scientific, $65 target
Oppenheimer maintained an Outperform rating on Boston Scientific and set a $65.00 price target, implying 50.0% upside versus the Sep 18 close of $43.34.
Oppenheimer maintained an Outperform rating on Boston Scientific and set a $65.00 price target, implying 50.0% upside versus the Sep 18 close of $43.34.